Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
VRDN holding history
Viridian Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRDN overviewAll 13F holders of VRDNFull Q1 2025 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −187−100.0% | Sold out | Holders |
| Q1 2024 | 187 | $3.27K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 187 | $4.07K | <0.1% | −81−30.2% | Reduced | Holders |
| Q3 2023 | 268 | $4.11K | <0.1% | +112+71.8% | Added | Holders |
| Q2 2023 | 156 | $3.71K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 156 | $3.97K | <0.1% | +156 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,006−100.0% | Sold out | Holders |
| Q2 2022 | 1,006 | $12.0K | <0.1% | +1,006 | New | Holders |